Hata Taishi, Ohara Nobuyoshi, Masuike Yasunori, Okamoto Kohei, Hata Tsuyoshi, Fujino Shiki, Yanagawa Takehiro, Kitahara Tomohiro, Oshima Kazuteru, Nagai Kenichi, Noda Takehiro, Miyake Masakazu, Kawanishi Kenshu, Morita Shunji, Fujita Junya, Iwazawa Takashi, Akagi Kenzo, Dono Keizo, Kitada Masashi
Dept. of Surgery, Toyonaka Municipal Hospital.
Gan To Kagaku Ryoho. 2011 Nov;38(12):2110-2.
The patient was a 53-year-old woman who underwent colonoscopy for anal pain and melena. We diagnosed her with Stage I (T2N0M0) anal canal squamous cell carcinoma by biopsy specimen and CT scan. We recommended chemo-radiotherapy because she hoped to keep her anus. For this patient, we planned an S-1 administration at a dose of 120 mg/ body/day for consecutive 14 days followed by 7 days of rest period with whole pelvis and bilateral inguinal radiation (total 45 Gy/25 Fr). Then we added a booster radiation (14 Gy/7 Fr) to a local area for 5 days followed by 2 days of rest period. After 2 weeks of chemo-radiotherapy, we could not detect any tumors by colonoscopy. We diagnosed it as a pathological complete response for biopsy specimen.
该患者为一名53岁女性,因肛门疼痛和黑便接受了结肠镜检查。通过活检标本和CT扫描,我们诊断她为I期(T2N0M0)肛管鳞状细胞癌。由于她希望保留肛门,我们建议进行放化疗。对于该患者,我们计划给予S-1,剂量为120mg/体/天,连续给药14天,随后休息7天,同时进行全盆腔和双侧腹股沟放疗(总量45Gy/25次分割)。然后我们对局部区域追加5天的强化放疗(14Gy/7次分割),随后休息2天。放化疗2周后,结肠镜检查未发现任何肿瘤。我们将活检标本诊断为病理完全缓解。